PSA-negative/low prostate cancer cells: the true villains of CRPC?

• 来源期刊: 亚洲男性学杂志（英文版）
• 年，卷（期）: 2012,（5）
• 页码范围: 663-664
• 页数: 2页
• 语种: 英文
• DOI: 10.1038/aja.2012.69

摘要

Prostate cancer remains a leaading cause of death in men in the United States.1,2 Treatment for advanced disease almost always includes androgen deprivation therapy (ADT)3 largely because the androgen receptor (AR) is expressed at high levels at many stages of disease progression.